Expression of B7-H3 Correlates with PD-L1 and Poor Prognosis in Patients with Cervical Cancer [Corrigendum]
Zhang Q, Zong L, Zhang H, et al. Onco Targets Ther. 2021;14:4275–4283. The authors have advised affiliation 1 on page 4275 is incorrect. The correct affiliation should read “Department of Obstetrics and Gynecology, Qilu Hospital, Cheeloo College of Medicine, Shandong University,...
Guardado en:
Autores principales: | Zhang Q, Zong L, Zhang H, Xie W, Yang F, Sun W, Cui B, Zhang Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fdc0da68f5fe4ef1bd2cc7d9c646ea7e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Expression of Programmed Cell Death-1 (PD-1) and Its Ligand (PD-L1) in Breast Cancers and Its Association with Clinicopathological Parameters: A Study from North India
por: Anoushika Mehan, et al.
Publicado: (2021) -
Posttranslational Modifications in PD-L1 Turnover and Function: From Cradle to Grave
por: Xinfang Yu, et al.
Publicado: (2021) -
Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway
por: Chunyi Shen, et al.
Publicado: (2021) -
Multifunctional Immunoliposomes Combining Catalase and PD-L1 Antibodies Overcome Tumor Hypoxia and Enhance Immunotherapeutic Effects Against Melanoma
por: Hei Y, et al.
Publicado: (2020) -
D-1 / PD-L1 EXPRESSION IN INVASIVE BREAST CARCINOMA / CANCER
por: Sammeen Salim, et al.
Publicado: (2021)